Biogen resurrects Alzheimer's drug, shares jump Biogen has today revealed surprise plans to seek US regulatory approval for its Alzheimer's treatment aducanumab. Business • 22 Oct 19
Biogen resurrects Alzheimer's drug, shares jump Biogen has today revealed surprise plans to seek US regulatory approval for its Alzheimer's treatment aducanumab. Business • 22 Oct 19
Biogen scraps Alzheimer drug trials Biogen and partner Eisai are ending two late-stage trials for the experimental Alzheimer's drug aducanumab. Business • 21 Mar 19
Biogen scraps Alzheimer drug trials Biogen and partner Eisai are ending two late-stage trials for the experimental Alzheimer's drug aducanumab. Business • 21 Mar 19
